7% clarify the target cells of GnRH in the ovary, in vivo expression of ovarian GnRH receptor mRNA was examined histologically by in situ hybridization in immature rats treated with PMSG only or in combination with hCG. Strong hybridization signals were observed in the granulosa cells of atretic fol
Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells
β Scribed by Bahk, J. Y. ;Hyun, J. S. ;Lee, B.H. ;Kim, M. O. ;Cho, G. J. ;Choi, W. S.
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 425 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The SNF2βrelated CBP activator protein (SRCAP) serves as a coactivator for several nuclear receptors including the androgen receptor (AR). SRCAP is an ATPase that is the core subunit of a large multiprotein complex and was shown to incorporate the histone variant H2A.Z into nucleosomes.
BACKGROUND. Continuous administration of gonadotropin-releasing hormone (GnRH) agonists in prostate cancer patients results in involution of the tumors due to suppression of androgen production. In addition to the effect of GnRH at the hypothalamic-pituitary level, experiments in vitro on breast, ov
## Background: Several recent studies have suggested an important role of the apoptosis suppressing bcl-2 gene product in prostate cancer progression to an androgen-insensitive disease. ## Methods: Using double-labeling techniques, we have investigated the nuclear androgen receptor (ar) status an